Related Experiment Videos
Life-threatening hyperkalemia in severe heart failure
S C Chakko1, J Frutchey, M Gheorghiade
1Veterans Administration Medical Center, Salem, Va.
American Heart Journal
|May 1, 1989
Summary
Severe heart failure patients on potassium therapy can develop life-threatening hyperkalemia. Early recognition and management are crucial for preventing fatal outcomes in these cardiac patients.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Potassium disturbances, including hyperkalemia, can complicate severe heart failure management.
- While hypokalemia is more common, hyperkalemia poses a significant risk in heart failure patients.
Observation:
- Nine episodes of acute, life-threatening hyperkalemia occurred in 6 out of 730 severe heart failure patients (0.8%).
- These events happened during maintenance oral potassium therapy, often with heart failure exacerbation or after additional potassium doses for hypokalemia.
- Mean serum potassium was 7.2 +/- 0.5 mEq/L; one episode was fatal, seven were treated successfully, and one resolved spontaneously.
Findings:
- Severe heart failure patients are at risk for hyperkalemia, even on oral potassium therapy.
- Hyperkalemia in this cohort was associated with exacerbations of heart failure and/or potassium repletion.
- Angiotensin-converting enzyme inhibitor use was infrequent in this specific group of hyperkalemic patients.
Implications:
- Clinicians must be aware of the potential for hyperkalemia in severe heart failure patients, particularly those on potassium supplementation.
- Prompt recognition and management strategies are vital for improving outcomes and reducing mortality.
- Monitoring potassium levels is essential in heart failure patients receiving potassium therapy, especially during clinical instability.